Abstract: A ready-to-use injectable, aqueous pharmaceutical composition for the treatment of cardiac conditions, comprising methyl-3-[4-(2-hydroxy-3-isopropylamino) propoxy] phenylpropionate hydrochloride (esmolol hydrochloride), a buffering agent and an osmotic-adjusting agent, as well as a method for its manufacture in a container, is disclosed.
Type:
Grant
Filed:
January 12, 2001
Date of Patent:
October 30, 2001
Assignee:
Baxter International Inc.
Inventors:
Jie Liu, Satish K. Pejaver, George Owoo